Emerging Biomarkers of Acute Myocardial Infarction, An Overview of the Newest MicroRNAs.

Globally, acute myocardial infarction (AMI) is the leading cause of death. Early and precise diagnosis is essential for medical care to enhance prognoses and reduce mortality. The diagnosis of AMI relies primarily on conventional circulating biomarkers.